Want to see OVID full AI Analyst Report?
Ovid Therapeutics (OVID) Ownership - Who Owns Ovid Therapeutics?
Ovid Therapeutics (OVID) Ownership Overview
- 6.72% Insiders
- 10.54% Mutual Funds
- 0.07% Other Institutional Investors
- 10.74% ETFs
- 71.92% Public Companies and Individual Investors
The ownership structure of Ovid Therapeutics (OVID) stock is a mix of institutional, retail, and individual investors. Approximately 21.36% of the company’s stock is owned by Institutional Investors, 6.72% is owned by Insiders, and 71.92% is owned by Public Companies and Individual Investors.
The ownership structure of Ovid Therapeutics (OVID) stock is a mix of institutional, retail, and individual investors. Approximately 21.36% of the company’s stock is owned by Institutional Investors, 6.72% is owned by Insiders, and 71.92% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Ra Capital Management | $28,247,604 | |
| Jun 30, 2026 | $29,115,161 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Peter Kolchinsky | 10,500,968 | Institution | 5.38% | 26,672,459 |
| Vanguard | 9,341,247 | Institution | 4.78% | 23,726,767 |
| Takeda Pharmaceutical Co Ltd | 8,781,996 | Insider | 4.50% | 22,306,270 |
| Vanguard Index Funds | 7,605,838 | Institution | 3.89% | 19,318,829 |
| Ishares | 6,561,671 | Institution | 3.36% | 16,666,644 |
| Federated Hermes Equity Funds | 4,166,166 | Institution | 2.13% | 10,582,062 |
| Jeremy Levin | 3,770,509 | Insider | 1.93% | 9,577,093 |
| Spdr | 3,317,131 | Institution | 1.70% | 8,425,513 |
| Mutual Fund Series Trust | 1,934,257 | Institution | 0.99% | 4,913,013 |
| Fidelity Salem Street Trust | 1,882,848 | Institution | 0.96% | 4,782,434 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 7,605,838 | Institution | 3.89% | 19,318,829 |
| Federated Hermes Equity Funds | 4,166,166 | Institution | 2.13% | 10,582,062 |
| Mutual Fund Series Trust | 1,934,257 | Institution | 0.99% | 4,913,013 |
| Fidelity Salem Street Trust | 1,882,848 | Institution | 0.96% | 4,782,434 |
| Fidelity Concord Street Trust | 1,632,166 | Institution | 0.84% | 4,145,702 |
| Vanguard Scottsdale Funds | 1,036,969 | Institution | 0.53% | 2,633,901 |
| Tiaa-cref Funds | 932,778 | Institution | 0.48% | 2,369,256 |
| Schwab Capital Trust | 529,277 | Institution | 0.27% | 1,344,364 |
| Dfa Investment Dimensions Group Inc | 139,847 | Institution | 0.07% | 355,211 |
| Bridgeway Funds, Inc. | 135,900 | Institution | 0.07% | 345,186 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VTI ETF | 5,653,216 | Institution | 2.89% | 14,076,508 |
| iShares, IWM ETF | 4,129,924 | Institution | 2.11% | 10,572,605 |
| SPDR, XBI ETF | 2,900,527 | Institution | 1.49% | 7,425,349 |
| Vanguard, VXF ETF | 2,020,287 | Institution | 1.03% | 5,030,515 |
| iShares, IWN ETF | 1,339,493 | Institution | 0.69% | 3,429,102 |
| Vanguard, VTWO ETF | 959,718 | Institution | 0.49% | 2,389,698 |
| Vanguard, VFMO ETF | 540,371 | Institution | 0.28% | 1,383,350 |
| Fidelity, FESM ETF | 529,687 | Institution | 0.27% | 1,355,999 |
| iShares, IWC ETF | 500,412 | Institution | 0.26% | 1,281,055 |
| iShares, ITOT ETF | 343,540 | Institution | 0.18% | 879,462 |
FAQ
Who Owns Ovid Therapeutics (OVID)?
According to the latest TipRanks data, approximately 21.36% of the company's stock is held by institutional investors, 6.72% is held by insiders, and 71.92% is held by public companies and individual investors.
What percentage of Ovid Therapeutics (OVID) stock is held by institutional investors?
According to the latest TipRanks data, approximately 21.36% of Ovid Therapeutics (OVID) stock is held by institutional investors: 10.54% by mutual funds, 10.74% by ETFs and 0.07% by other institutional investors.
What percentage of Ovid Therapeutics (OVID) stock is held by retail investors?
According to the latest TipRanks data, approximately 71.92% of Ovid Therapeutics (OVID) stock is held by public companies and individual investors.
Who owns the most shares of Ovid Therapeutics (OVID)?
Peter Kolchinsky owns the most shares of Ovid Therapeutics (OVID).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.